Renephra Ltd is a medical device company, developing a groundbreaking technology for minimally invasive fluid removal to addresses the significant problems of fluid overload and chronic oedema / lymphoedema in vascular, oncology and other disease areas. This is a substantial patient group with unmet clinical needs and is an estimated £1.8 billion market worldwide. Recently Renephra achieved proof of concept in humans and is now engaged in raising capital to develop and CE mark the first device.
Phone: 9428983

Investors 1

Mentions in press and media 1

29.03.2018Renephra R...Renephra, a Manchester, UK-bas...UK-finsmes.co...